Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/53763
Full metadata record
DC FieldValueLanguage
dc.contributor.authorE. J. Hendricksen_US
dc.contributor.authorM. Srisurapanonten_US
dc.contributor.authorS. L. Schmidten_US
dc.contributor.authorM. Haggarden_US
dc.contributor.authorS. Souteren_US
dc.contributor.authorC. L. Mitchellen_US
dc.contributor.authorD. G. De Marcoen_US
dc.contributor.authorM. J. Hendricksen_US
dc.contributor.authorY. Istratiyen_US
dc.contributor.authorF. L. Greenwayen_US
dc.date.accessioned2018-09-04T09:57:20Z-
dc.date.available2018-09-04T09:57:20Z-
dc.date.issued2014-02-01en_US
dc.identifier.issn14765497en_US
dc.identifier.issn03070565en_US
dc.identifier.other2-s2.0-84896690350en_US
dc.identifier.other10.1038/ijo.2013.74en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84896690350&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/53763-
dc.description.abstractObjective:To investigate if phentermine treatment induces phentermine abuse, psychological dependence (addiction) or phentermine drug craving in overweight, obese and weight loss maintenance patients. To investigate whether amphetamine-like withdrawal occurs after abrupt cessation of long-term phentermine treatment.Design:Clinical intervention trial with interruption of phentermine treatment in long-term patients.Subjects:269 obese, overweight or formerly obese subjects (age: 20-88 years, BMI: 21-74 kg m -2) treated with phentermine long-term (LTP, N=117), 1.1-21.1 years, or short-term (ATP, N=152), 4-22 days, with phentermine doses of 18.75-112.5 (LTP) and 15-93.75 (ATP) mg per day.Measurements:Module K of the Mini International Neuropsychiatric Interview modified for phentermine (MINI-SUD), Severity of Dependence Scale (SDS), 45-item Cocaine Craving Questionnaire-NOW (CCQ-NOW) modified for phentermine (PCQ-NOW), and Amphetamine Withdrawal Questionnaire (AWQ) modified for phentermine (PWQ).Results:MINI-SUD interviews were negative for phentermine abuse or psychological dependence in all LTP patients. SDS examination scores were low for all LTP and ATP patients, indicating they were not psychologically dependent upon phentermine. PCQ-NOW scores were low for all LTP and ATP patients, indicating neither short-term nor long-term phentermine treatment had induced phentermine craving. Other than an increase in hunger or eating, amphetamine-like withdrawal symptoms did not occur upon abrupt phentermine cessation as measured by sequential PWQ scores.Conclusions:Phentermine abuse or psychological dependence (addiction) does not occur in patients treated with phentermine for obesity. Phentermine treatment does not induce phentermine drug craving, a hallmark sign of addiction. Amphetamine-like withdrawal does not occur upon abrupt treatment cessation even at doses much higher than commonly recommended and after treatment durations of up to 21 years. © 2014 Macmillan Publishers Limited.en_US
dc.subjectMedicineen_US
dc.subjectNursingen_US
dc.titleAddiction potential of phentermine prescribed during long-term treatment of obesityen_US
dc.typeJournalen_US
article.title.sourcetitleInternational Journal of Obesityen_US
article.volume38en_US
article.stream.affiliationsCenter for Weight Managementen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsUniversity of Colorado Health Sciences Centeren_US
article.stream.affiliationsPennington Biomedical Research Centeren_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.